The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 41, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-03
DOI
10.1186/s13046-022-02394-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype
- (2022) Serena Mancarella et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression
- (2022) Tingjie Wang et al. HEPATOLOGY
- Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice
- (2021) Yi Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice
- (2021) Xinjun Lu et al. AMERICAN JOURNAL OF PATHOLOGY
- TAZ is indispensable for c-MYC-induced hepatocarcinogenesis
- (2021) Haichuan Wang et al. JOURNAL OF HEPATOLOGY
- Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma
- (2021) Marcell Tóth et al. BMC CANCER
- Fibroblast growth factor receptor fusions in cancer: opportunities and challenges
- (2021) Lingfeng Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis
- (2021) Yuchen Liu et al. JOURNAL OF HEPATOLOGY
- YAP/TAZ functions and their regulation at a glance
- (2020) Arianna Pocaterra et al. JOURNAL OF CELL SCIENCE
- The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans
- (2020) Shu Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- The Hippo Pathway in Liver Homeostasis and Pathophysiology
- (2020) Jordan H. Driskill et al. Annual Review of Pathology-Mechanisms of Disease
- Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis
- (2020) Elisabeth Verboven et al. GASTROENTEROLOGY
- WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis
- (2019) Yu-An Chen et al. Frontiers in Oncology
- Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
- (2019) Maria Maddalena Simile et al. Medicina-Lithuania
- YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
- (2019) Matthias Van Haele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of a pan-gamma-secretase inhibitor response signature for notch-driven cholangiocarcinoma
- (2019) Colm J. O'Rourke et al. HEPATOLOGY
- Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis
- (2019) Jingxiao Wang et al. JOURNAL OF HEPATOLOGY
- The Hippo Signaling Pathway in Development and Disease
- (2019) Yonggang Zheng et al. DEVELOPMENTAL CELL
- The Hippo Signaling Network and its Biological Functions
- (2018) Jyoti R. Misra et al. Annual Review of Genetics
- Ductular reaction in liver diseases: pathological mechanisms and translational significances
- (2018) Keisaku Sato et al. HEPATOLOGY
- Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
- (2017) Shanshan Zhang et al. JOURNAL OF HEPATOLOGY
- Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis
- (2017) Yuhree Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma
- (2016) Heng Xiao et al. CANCER LETTERS
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- (2016) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease
- (2016) Maria M. Simile et al. Oncotarget
- Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans
- (2016) L Che et al. Oncogenesis
- Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma
- (2015) Yan Guo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Hippo signaling pathway in liver regeneration and tumorigenesis
- (2014) L. Hong et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
- (2014) Xin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Hippo Pathway Activity Influences Liver Cell Fate
- (2014) Dean Yimlamai et al. CELL
- Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice
- (2014) Junyan Tao et al. GASTROENTEROLOGY
- YAP activation is an early event and a potential therapeutic target in liver cancer development
- (2014) Andrea Perra et al. JOURNAL OF HEPATOLOGY
- The Biology of YAP/TAZ: Hippo Signaling and Beyond
- (2014) Stefano Piccolo et al. PHYSIOLOGICAL REVIEWS
- Cholangiocarcinomas can originate from hepatocytes in mice
- (2012) Biao Fan et al. JOURNAL OF CLINICAL INVESTIGATION
- Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
- (2012) Sayaka Sekiya et al. JOURNAL OF CLINICAL INVESTIGATION
- Deregulation of Hippo kinase signalling in Human hepatic malignancies
- (2011) Hua Li et al. LIVER INTERNATIONAL
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
- (2010) Nailing Zhang et al. DEVELOPMENTAL CELL
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver
- (2010) S. Benhamouche et al. GENES & DEVELOPMENT
- Immunohistochemical classification of ductular reactions in human liver
- (2010) Eszter Turányi et al. HISTOPATHOLOGY
- Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
- (2010) H. Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
- (2010) K.-P. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
- (2009) Michelle Z. Xu et al. CANCER
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
- (2009) Dawang Zhou et al. CANCER CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started